Evidence map›Paper›PMID 32962318›Full record

ArticleInternational journal of molecular sciences2017

The Future of DNA Adductomic Analysis.

Peter W Villalta, Silvia Balbo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. A Novel Adductomics Workflow IncorporatingEnvironmental science & technology · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. A Comprehensive Database for DNA Adductomics.Frontiers in chemistry · 2022
    Article
  14. DNA Adductomics by mass tag prelabeling.Rapid communications in mass spectrometry : RCM · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Peter W VillaltaMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0002-0067-3083
Silvia BalboMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
University of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

NIH National Cancer Institute R50 CA-211256
6 · The paper itself

Abstract

Covalent modification of DNA, resulting in the formation of DNA adducts, plays a central role in chemical carcinogenesis. Investigating these modifications is of fundamental importance in assessing the mutagenicity potential of specific exposures and understanding their mechanisms of action. Methods for assessing the covalent modification of DNA, which is one of the initiating steps for mutagenesis, include immunohistochemistry,

Indexed as

chemical carcinogenesisconstant neutral lossDNA adductomicsDNA adductsDNA damagegenotoxicityhigh resolution accurate mass (HRAM) mass spectrometry

Identifiers

PMID32962318
PMCPMC5618519
OpenAlexW2751815788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.